Markets:

Overview

News

Currencies

International

Treasuries

Stryker Corp (NY:SYK)

369.56 +15.26 (+4.31%)

Official Closing Price Updated: 4:10 PM EST, Jan 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Stryker Corp

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

Explore the top gainers and losers within the S&P500 index in today's session. ↗

Today 15:05 EST

Via Chartmill

Stryker Corp (NYSE:SYK) Beats Q4 EPS Estimates, Provides 2026 Guidance ↗

January 29, 2026

Via Chartmill

Stryker (SYK) Q4 2025 Earnings Call Transcript ↗

January 29, 2026

Stryker (SYK) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings World Trade

Stryker’s (NYSE:SYK) Q4 CY2025 Sales Top Estimates

January 29, 2026

Medical technology company Stryker (NYSE:SYK) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 11.4% year on year to $7.17 billion. Its non-GAAP profit of $4.47 per...

Via StockStory

Stryker reports 2025 operating results and 2026 outlook

January 29, 2026

From Stryker Corporation

Via GlobeNewswire

Boston Scientific to Acquire Penumbra for $14.5 Billion in Massive MedTech Consolidation

January 28, 2026

MARLBOROUGH, Mass. — In a move that has sent shockwaves through the medical technology landscape, Boston Scientific (NYSE: BSX) announced on January 15, 2026, a definitive agreement to acquire Penumbra...

Via MarketMinute

What To Expect From Stryker’s (SYK) Q4 Earnings

January 27, 2026

Medical technology company Stryker (NYSE:SYK) will be reporting results this Thursday after market close. Here’s what to expect.

Via StockStory

The $14.5 Billion Clot-Bust: Boston Scientific’s Bold Bet on Penumbra Signals a New Era of Medtech Giants

January 27, 2026

In a move that has sent shockwaves through the healthcare sector, Boston Scientific Corporation (NYSE: BSX) announced on January 15, 2026, its definitive agreement to acquire Penumbra, Inc. (NYSE: PEN)...

Via MarketMinute

2 Cash-Producing Stocks to Consider Right Now and 1 Facing Headwinds

January 25, 2026

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...

Via StockStory

1 Healthcare Stock Worth Your Attention and 2 We Avoid

January 15, 2026

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have...

Via StockStory

Topics Stocks

The Thrombectomy Titan: Boston Scientific Shakes MedTech with $14.5 Billion Penumbra Acquisition

January 15, 2026

MARLBOROUGH, MA – In a move that has sent shockwaves through the medical device sector, Boston Scientific Corporation (NYSE:BSX) announced today, January 15, 2026, a definitive agreement to acquire...

Via MarketMinute

Topics Artificial Intelligence

The Great Diagnostic Consolidation: How a $25.7 Billion Mega-Deal Ignited a 150% Surge in Healthcare M&A

January 14, 2026

As 2026 begins, the healthcare sector is undergoing its most profound transformation in decades. Driven by a relentless push toward "precision medicine" and the industrialization of artificial...

Via MarketMinute

Topics Artificial Intelligence

The Great Recalibration: Why 2026 Could Be Healthcare’s Year to Rebound

January 13, 2026

For the past two years, the U.S. healthcare sector has been the forgotten stepchild of the equity markets. As the S&P 500 (SPX) surged on the back of an artificial intelligence gold rush and a...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

Healthcare Bellwether Braces for Impact: UnitedHealth Group’s High-Stakes Q4 Outlook Signals a Sector-Wide Reset

January 13, 2026

As the 44th Annual J.P. Morgan Healthcare Conference kicked off this week in San Francisco, all eyes turned to UnitedHealth Group (NYSE:UNH), the diversified healthcare giant that serves as the primary...

Via MarketMinute

Topics Earnings Economy Stocks

Medtronic (MDT) Deep-Dive: Can the MedTech Giant Outpace the Market in 2026?

January 09, 2026

Date: January 9, 2026 Introduction As the global healthcare landscape undergoes a seismic shift toward personalized medicine and AI-integrated care, Medtronic plc (NYSE: MDT) stands at a critical...

Via PredictStreet

Topics Artificial Intelligence Economy Product Recall

1 Oversold Stock Primed to Rebound and 2 That Underwhelm

January 06, 2026

Rock-bottom prices don't always mean rock-bottom businesses. The stocks we're examining today have all touched their 52-week lows, creating a classic investor's dilemma: bargain opportunity or value...

Via StockStory

Stryker (SYK) Stock Trades Up, Here Is Why

January 06, 2026

Shares of medical technology company Stryker (NYSE:SYK) jumped 4.1% in the afternoon session after analyst firm Raymond James upgraded the stock to "Outperform" from "Market Perform" and set a $418...

Via StockStory

Topics Artificial Intelligence Economy Government

Why Stryker Stock Popped Today ↗

January 06, 2026

Does a 10% growth rate justify a 46x earnings stock price?

Via The Motley Fool

The Great Rebalancing: Why Healthcare is Leading the Market Charge in 2026

January 06, 2026

As the first week of 2026 draws to a close, a distinct shift in market leadership has become the defining story for Wall Street. After a multi-year period where technology and artificial intelligence...

Via MarketMinute

Topics Artificial Intelligence Economy Government

Stryker to announce financial results for its fourth quarter and full year 2025

January 05, 2026

From Stryker Corporation

Via GlobeNewswire

2 Large-Cap Stocks with Solid Fundamentals and 1 Facing Challenges

December 30, 2025

Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth...

Via StockStory

Baxter International (BAX) in 2025: A Deep Dive into the Transformation of a MedTech Giant

December 26, 2025

As of December 26, 2025, Baxter International Inc. (NYSE: BAX) stands at a pivotal crossroads in its nearly century-long history. Long considered a defensive "blue-chip" staple of the healthcare...

Via PredictStreet

Topics Economy Emissions Product Recall

Is Fidelity Medical Equipment the Ultimate "Forever Fund" for Health Care Investors? ↗

December 24, 2025

This basket of 64 medical device stocks could raise its dividend for decades.

Via The Motley Fool

Topics ETFs Government Supply Chain

Dow Jones Soars to New Highs Amidst Economic Crosscurrents and AI Jitters

December 17, 2025

New York, NY – December 17, 2025 – The Dow Jones Industrial Average (DJIA) has concluded December 2025 with a notable ascent, marking a period of robust performance that has seen the index reach new...

Via MarketMinute

Topics Artificial Intelligence Economy Government

Profit Powerhouse: Strong Earnings Outlook Defies Market Slips, Signaling Continued Bull Run for US Stocks

December 16, 2025

Despite recent pockets of volatility and "slips" in the U.S. stock market during late 2025, a robust corporate profit outlook is emerging as a powerful counter-narrative, fueling investor optimism and...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

3 Healthcare Giants Just Raised Dividends—Here’s Who Pays the Most ↗

December 16, 2025

Via MarketBeat

The Great Divergence: Dow Soars to Record Highs While Nasdaq Tech Stumbles

December 11, 2025

December 11, 2025 – The U.S. stock market is currently witnessing a striking and arguably unprecedented divergence, as the Dow Jones Industrial Average (DJIA) continues its ascent to record highs,...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

Stryker declares an $0.88 per share quarterly dividend

December 11, 2025

From Stryker Corporation

Via GlobeNewswire

3 Reasons Investors Watch Stryker (SYK)

December 09, 2025

Over the past six months, Stryker’s shares (currently trading at $350.50) have posted a disappointing 9% loss, well below the S&P 500’s 13.4% gain. This may have investors wondering how to approach the...

Via StockStory

Topics Stocks Supply Chain

Stryker names Spencer Stiles President and Chief Operating Officer

December 04, 2025

Dylan Crotty promoted to Group President, Orthopaedics

From Stryker Corporation

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.